All Stories

  1. Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice

    Article • Diabetes Metabolic Syndrome and Obesity, August 2019, Taylor & Francis

    Dr Kohichiroh Yasui, Wataru Aoi

  2. Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis

    Article • Diabetes Metabolic Syndrome and Obesity, November 2018, Dove Medical Press

    Dr Kohichiroh Yasui

  3. Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease

    Article • Hepatology Research, July 2017, Wiley

    Dr Kohichiroh Yasui

  4. EVI 1 , a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinoma

    Article • Cancer Science, June 2015, Wiley

    Dr Kohichiroh Yasui

  5. Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma

    Article • Hepatology Research, April 2014, Wiley

    Dr Kohichiroh Yasui